By JENNIFER
CORBETT DOOREN and TIMOTHY
W. MARTIN
The outbreak of a rare form of meningitis is prompting some doctors to
rethink their use of a specialized type of pharmacy that created steroid
injections tied to 119 illnesses and 12 deaths.
MedStar Health, a health-care provider that includes Georgetown University
and Washington Hospital Center in Washington, D.C., said it is reconsidering its
currently limited use of compounding pharmacies, which create alternative
versions of medicines, such as liquid forms of pills. "I think the whole
[health-care] industry is going to undergo some serious internal rethinking,"
said Bonnie Levin, assistant vice president for pharmacy services at MedStar To read the rest of the WSJ article click here.
No comments:
Post a Comment